{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:27:49Z","timestamp":1793831269907,"version":"4.6.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.healun.2018.01.1291","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T06:55:36Z","timestamp":1517381736000},"page":"537-547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":164,"title":["The management of antibodies in heart transplantation: An ISHLT consensus document"],"prefix":"10.1016","volume":"37","author":[{"given":"Jon","family":"Kobashigawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Colvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Potena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duska","family":"Dragun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Crespo-Leiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Olymbios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6511-295X","authenticated-orcid":false,"given":"Jayan","family":"Parameshwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jignesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Reinsmoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Rene","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4384-3027","authenticated-orcid":false,"given":"Heather","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall C.","family":"Starling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolly","family":"Tyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Urschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zuckermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2018.01.1291_bib1","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.athoracsur.2007.05.095","article-title":"Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era","volume":"84","author":"Nwakanma","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2018.01.1291_bib2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-6143.2010.03383.x","article-title":"De novo donor HLA\u2010specific antibodies after heart transplantation are an independent predictor of poor patient survival","volume":"11","author":"Smith","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.humimm.2009.04.018","article-title":"Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival","volume":"70","author":"Vlad","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2018.01.1291_bib4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/01.tp.0000180564.14050.49","article-title":"The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome","volume":"80","author":"Tambur","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2018.01.1291_bib5","first-page":"921","article-title":"Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation","volume":"10","author":"Lavee","year":"1990","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/ajt.13529","article-title":"Late failing heart allografts: pathology of cardiac allograft vasculopathy and association with antibody\u2010mediated rejection","volume":"16","author":"Loupy","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib7","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrneph.2016.88","article-title":"The importance of non-HLA antibodies in transplantation","volume":"12","author":"Zhang","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.healun.2018.01.1291_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.molmed.2015.02.004","article-title":"The perfect storm: HLA antibodies, complement, Fc\u03b3Rs, and endothelium in transplant rejection","volume":"21","author":"Thomas","year":"2015","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.healun.2018.01.1291_bib9","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/ajt.13174","article-title":"Monocyte recruitment by HLA IgG\u2010activated endothelium: the relationship between IgG subclass and Fc\u03b3RIIa polymorphisms","volume":"15","author":"Valenzuela","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib10","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/ajt.13273","article-title":"An anti\u2010C1s monoclonal, TNT003, inhibits complement activation induced by antibodies against HLA","volume":"15","author":"Thomas","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-6143.2011.03836.x","article-title":"A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody","volume":"12","author":"Hirohashi","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib12","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/ajt.12669","article-title":"Everolimus inhibits anti\u2010HLA I antibody\u2010mediated endothelial cell signaling, migration and proliferation more potently than sirolimus","volume":"14","author":"Jin","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib13","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.4049\/jimmunol.180.4.2357","article-title":"HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway","volume":"180","author":"Jindra","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2018.01.1291_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2001158","article-title":"HLA class I molecules partner with integrin \u03b24 to stimulate endothelial cell proliferation and migration","volume":"3","author":"Zhang","year":"2010","journal-title":"Sci Signal"},{"key":"10.1016\/j.healun.2018.01.1291_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00030","article-title":"Alloantibody generation and effector function following sensitization to human leukocyte antigen","volume":"7","author":"Hickey","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.healun.2018.01.1291_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/ajt.12016","article-title":"Blockade of P\u2010selectin is sufficient to reduce MHC I antibody\u2010elicited monocyte recruitment in vitro and in vivo","volume":"13","author":"Valenzuela","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib17","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.1201434","article-title":"HLA class I antibodies trigger increased adherence of monocytes to endothelial cells by eliciting an increase in endothelial P-selectin and, depending on subclass, by engaging Fc\u03b3Rs","volume":"190","author":"Valenzuela","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2018.01.1291_bib18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/TP.0b013e3182985504","article-title":"Anti-donor HLA class I antibodies: pathways to endothelial cell activation and cell-mediated allograft rejection","volume":"96","author":"Naemi","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2018.01.1291_bib19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2018.01.1291_bib20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(75)91209-X","article-title":"Lymphocyte-dependent antibody cross-matching for transplant patients","volume":"305","author":"Ting","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2018.01.1291_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2018.01.1291_bib22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.healun.2014.02.013","article-title":"Practical value of identifying antibodies to cryptic HLA epitopes in cardiac transplantation","volume":"33","author":"Oaks","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.yexmp.2015.11.023","article-title":"Complement-fixing antibodies against denatured HLA and MICA antigens are associated with antibody mediated rejection","volume":"100","author":"Cai","year":"2016","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.healun.2018.01.1291_bib24","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/ajt.12287","article-title":"Comprehensive assessment and standardization of solid phase multiplex\u2010bead arrays for the detection of antibodies to HLA","volume":"13","author":"Reed","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib25","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.humimm.2011.07.001","article-title":"Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads","volume":"72","author":"Chen","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2018.01.1291_bib26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.healun.2010.08.020","article-title":"Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients","volume":"30","author":"Chin","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/TP.0b013e318203fd26","article-title":"C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation","volume":"91","author":"Yabu","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2018.01.1291_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1399-3046.2011.01599.x","article-title":"Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss","volume":"16","author":"Sutherland","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib29","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2018.01.1291_bib30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.humimm.2009.04.016","article-title":"Clinical relevance of complement-fixing antibodies in cardiac transplantation","volume":"70","author":"Rose","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2018.01.1291_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1681\/ASN.2013101144","article-title":"Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss","volume":"26","author":"Sicard","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2018.01.1291_bib32","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.humimm.2009.06.015","article-title":"Alloantibodies in heart transplantation","volume":"70","author":"Ho","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2018.01.1291_bib33","first-page":"229","article-title":"Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant","volume":"6","author":"Kaczmarek","year":"2008","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib34","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.healun.2011.06.005","article-title":"Allosensitization and outcomes in pediatric heart transplantation","volume":"30","author":"Mahle","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib35","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.healun.2014.08.003","article-title":"The Registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report\u20142014; Focus theme: Retransplantation","volume":"33","author":"Lund","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib36","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.healun.2015.08.003","article-title":"The Registry of the International Society for Heart and Lung Transplantation: thirty-second official adult heart transplantation report\u20142015; Focus theme: Early graft failure","volume":"34","author":"Lund","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib37","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.healun.2013.08.014","article-title":"HLA and MICA allosensitization patterns among patients supported by ventricular assist devices","volume":"32","author":"Askar","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib38","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/TP.0b013e3182985371","article-title":"LVAD implant as a bridge to heart transplantation is associated with allosensitization as measured by single antigen bead assay","volume":"96","author":"Shankar","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2018.01.1291_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.healun.2009.08.028","article-title":"Ventricular assist device-associated anti-human leukocyte antigen antibody sensitization in pediatric patients bridged to heart transplantation","volume":"29","author":"O'Connor","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib40","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jtcvs.2011.07.019","article-title":"Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort","volume":"142","author":"Arnaoutakis","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2018.01.1291_bib41","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.healun.2015.12.023","article-title":"Influence of durable mechanical circulatory support and allosensitization on mortality after heart transplantation","volume":"35","author":"Chiu","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.healun.2008.12.017","article-title":"Report from a consensus conference on the sensitized patient awaiting heart transplantation","volume":"28","author":"Kobashigawa","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.humimm.2010.10.013","article-title":"Pre-and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival","volume":"72","author":"Ho","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2018.01.1291_bib44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-6143.2009.02877.x","article-title":"Absence of donor\u2010specific anti\u2010HLA antibodies after ABO\u2010incompatible heart transplantation in infancy: altered immunity or age?","volume":"10","author":"Urschel","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib45","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.healun.2016.10.016","article-title":"Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation","volume":"36","author":"Clerkin","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib46","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/TP.0b013e318244f7b8","article-title":"Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody","volume":"93","author":"Hodges","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2018.01.1291_bib47","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.healun.2015.03.002","article-title":"Late antibody-mediated rejection after heart transplantation: mortality, graft function, and fulminant cardiac allograft vasculopathy","volume":"34","author":"Coutance","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib48","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.healun.2012.12.005","article-title":"Correlation of circulating donor-specific anti-HLA antibodies and presence of C4d in endomyocardial biopsy with heart allograft outcomes: a single-center, retrospective study","volume":"32","author":"Frank","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.healun.2012.09.021","article-title":"Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients","volume":"32","author":"Zeevi","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib50","first-page":"A14016","article-title":"The development of de novo anti-HLA antibodies after heart transplant is related to the development of rejection depending of their complement fixing capability","volume":"126","author":"Farrero Torres","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2018.01.1291_bib51","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody\u2010mediated rejection and nonadherence","volume":"12","author":"Sellares","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib52","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/ajt.12162","article-title":"A survey of current practice for antibody-mediated rejection in heart transplantation","volume":"13","author":"Chih","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib53","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/00007890-200104150-00011","article-title":"Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation","volume":"71","author":"Jurcevic","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2018.01.1291_bib54","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/0140-6736(92)91832-S","article-title":"Anti-endothelial antibodies and coronary artery disease after cardiac transplantation","volume":"339","author":"Dunn","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2018.01.1291_bib55","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.healun.2009.01.003","article-title":"Anti-MICA antibodies are related to adverse outcome in heart transplant recipients","volume":"28","author":"Kauke","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib56","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/TP.0b013e3182692ad2","article-title":"Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation","volume":"94","author":"Hiemann","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2018.01.1291_bib57","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1600-6143.2007.01838.x","article-title":"The relationship of anti\u2010MICA antibodies and MICA expression with heart allograft rejection","volume":"7","author":"Su\u00e1rez\u2010\u00c1lvarez","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib58","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/TP.0b013e3182157d60","article-title":"HLA and MICA: targets of antibody-mediated rejection in heart transplantation","volume":"91","author":"Zhang","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2018.01.1291_bib59","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1\u2013receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2018.01.1291_bib60","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0041-1345(98)00172-9","article-title":"Use of intravenous immunoglobulin in sensitized LVAD recipients","volume":"30","author":"Dowling","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2018.01.1291_bib61","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00007890-199210000-00017","article-title":"Outcome of cardiac transplant recipients with a positive donor-specific crossmatch\u2014preliminary results with plasmapheresis","volume":"54","author":"Ratkovec","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2018.01.1291_bib62","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1111\/j.1600-6143.2010.03226.x","article-title":"Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation","volume":"10","author":"Bartel","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib63","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1016\/j.transproceed.2016.06.061","article-title":"Safety and efficacy of immunoadsorption in heart transplantation program","volume":"48","author":"Gazdic","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2018.01.1291_bib64","first-page":"201","article-title":"Efficacy of immunoadsorption to reduce donor-specific alloantibodies in kidney-transplant candidates","volume":"13","author":"Rostaing","year":"2015","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib65","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1111\/j.1399-0012.2010.01334.x","article-title":"The long-term outcome of treated sensitized patients who undergo heart transplantation","volume":"25","author":"Kobashigawa","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib66","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/circ.100.suppl_2.Ii-229","article-title":"Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients","volume":"100","author":"John","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2018.01.1291_bib67","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1034\/j.1399-0012.17.s9.3.x","article-title":"Cardiac transplantation across a positive prospective lymphocyte cross-match in sensitized recipients","volume":"17","author":"Leech","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib68","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.healun.2011.08.009","article-title":"Reduction of alloantibodies via proteasome inhibition in cardiac transplantation","volume":"30","author":"Patel","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib69","first-page":"161","article-title":"Allosensitization in heart transplantation: an overview","volume":"30","author":"Al-Mohaissen","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.healun.2018.01.1291_bib70","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.healun.2015.10.013","article-title":"Optimizing transplantation of sensitized heart candidates using 4 antibody detection assays to prioritize the assignment of unacceptable antigens","volume":"35","author":"Reinsmoen","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib71","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/ajt.13071","article-title":"Comparison of listing strategies for allosensitized heart transplant candidates requiring transplant at high urgency: a decision model analysis","volume":"15","author":"Feingold","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib72","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/ajt.13168","article-title":"Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1 year","volume":"15","author":"Cornell","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib73","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1016\/j.transproceed.2006.10.060","article-title":"Effect of plasmapheresis for acute humoral rejection after heart transplantation","volume":"38","author":"Wang","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2018.01.1291_bib74","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00007890-199809270-00017","article-title":"Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action","volume":"66","author":"Jordan","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2018.01.1291_bib75","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIR.0000000000000093","article-title":"Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association","volume":"131","author":"Colvin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2018.01.1291_bib76","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.healun.2007.01.027","article-title":"Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review","volume":"26","author":"Kaczmarek","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib77","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/MOT.0b013e328330f304","article-title":"Proteasome inhibition for antibody-mediated rejection","volume":"14","author":"Everly","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib78","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.healun.2005.10.004","article-title":"Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis","volume":"25","author":"Kirklin","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.01.1291_bib79","first-page":"902","article-title":"Total lymphoid irradiation in the treatment of early or recurrent heart rejection","volume":"11","author":"Salter","year":"1992","journal-title":"J Heart Lung Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249818312920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249818312920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:35:35Z","timestamp":1760949335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249818312920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":79,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1053249818312920"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2018.01.1291","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The management of antibodies in heart transplantation: An ISHLT consensus document","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2018.01.1291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for the Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}